Vo Thomas T.'s Form 4 filing

Nutex Health Inc. (NUTX) · filed Nov 21, 2023

Accession no.: 0001486189-23-000042
Filed: Nov 21, 2023, 2:24 PM ET
Trade date: Nov 17-20, 2023
Filing delay: 4 days
Rule 10b5-1 plan: Not checked

Original on SEC EDGAR (opens in a new tab)

This filing lists 2 non-derivative transactions. Open-market purchases total $113.9K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
Owner	Relationship to the company
Vo Thomas T.CIK 0001919945	Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade date	Security	Transaction	Shares	Price	Value	Shares after	Ownership	Flags
Nov 17, 2023	Common Stock	PPurchaseAcquired	+224,800	$0.23^F1	+$51,704	269,547,576	Indirect
Nov 20, 2023	Common Stock	PPurchaseAcquired	+275,200	$0.226^F2	+$62,195.2	269,822,776	Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.2172 to $0.2395, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

Referenced by the price of 1 transaction in Table I.

. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $00.2221 to $0.2370, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (2) to this Form 4.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)